Bibliography for: "Johnson & Johnson's popular epilepsy drug Topamax is showing promise as a treatment for migraine headaches - topiramate - Product News in Brief"

"Johnson & Johnson's popular epilepsy drug Topamax is showing promise as a treatment for migraine headaches - topiramate - Product News in Brief". Drug Cost Management Report. FindArticles.com. 26 Dec, 2009. http://findarticles.com/p/articles/mi_m0NKV/is_10_3/ai_92712200/

Drug Cost Management Report

View more issues:

Articles in Oct, 2002 issue of Drug Cost Management Report

• The Centers for Medicare & Medicaid Services has issued the final regulation establishing the Medicare-Endorsed Prescription Drug Card Assistance Initiative - CMS - Drug Cost Strategies in Brief
• AstraZeneca's antipsychotic Seroquel , used to treat schizophrenia, could be an effective therapy for bipolar disorder - quetiapine - Product News in Brief
• A survey sponsored by Pfizer demonstrates the effects of direct-to-consumer ads on African-American patients - DTC - Drug Cost Studies in Brief
• Novartis Pharmaceuticals has received FDA approval to market Ritalin LA - long acting - Product News in Brief
• Health plans should promote use of generic drugs because it saves money and patients want them to - Drug Cost Strategies in Brief
• Eli Lilly has received an approvable letter from FDA for a new depression therapy - Product News in Brief
• There is a new method for identifying potential adverse drug events and preventing them - ADEs - Drug Cost Studies in Brief
• Pfizer's novel drug pregabalin is showing promise as a new treatment for generalized anxiety disorder - Product News in Brief
• Kentucky Medicaid puts Zyprexa on prior authorization
• Johnson & Johnson's popular epilepsy drug Topamax is showing promise as a treatment for migraine headaches - topiramate - Product News in Brief
• The way physicians communicate with patients can have a significant impact on the effectiveness of antidepressant medications - Drug Cost Studies in Brief
• New data on Eli Lilly's Zyprexa show that it is more effective than lithium for treating bipolar disorder - Product News in Brief
• Schering-Plough has sponsored a study demonstrating the advantages of Claritin versus Benadryl - loratadine - Drug Cost Studies in Brief
• The National Consumers League is encouraging the FDA to revise warning labels on over-the-counter nonsteroidal anti-inflammatory drugs - NCL - OTC - NSAIDs - Product News in Brief
• Formulary compliance, patient safety to improve as physicians take up e-prescribing
• Prescription Solutions, the PBM subsidiary of PacifiCare Health Systems, has won a contract to provide mail service to clients of MedE America - Contracts and Alliances in Brief
• Coming in November
• Rx benefit represents 12% of employer health care costs, survey shows
• Express Scripts has been awarded a contract from the U.S. Department of Defense to provide mail-order pharmacy services for the TRICARE Mail Order Pharmacy Program - Contracts and Alliances in Brief
• Pfizer and Parke-Davis have merged their discount card programs - Company News in Brief
• Medco cites spike in pediatric Rx spending; touts tiered coinsurance, value-based formulary
• AdvancePCS' specialty pharmacy subsidiary, Theracom Inc., has won a contract from Sankyo Pharma - Contracts and Alliances in Brief
• NMHCRX, the PBM subsidiary of National Medical Health Card Systems, reported fourth quarter revenue of $146.0 million revenue - Company News in Brief